Home » Higher Law: FDA Routes ‘New Regulatory Pathway for CBD’ Through Congress

Higher Law: FDA Routes ‘New Regulatory Pathway for CBD’ Through Congress

by John Hensley

[ad_1]

Welcome back to Higher Law, our weekly briefing on all things cannabis. I’m Cheryl Miller, reporting for Law.com from Sacramento. 

This week we’re looking at:

  • The FDA’s punt to Congress on CBD rules.
  • Marijuana, marionberries and the Dormant Commerce Clause.
  • A lawyer elected director of the Minority Cannabis Business Association.
  • AI and cannabis law.

[ad_2]

Source link

You may also like